Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear As Compared to Anterior Cruciate Ligament Injury

Overview

Journal Immune Netw

Specialty Allergy & Immunology

Date 2024 May 10

PMID 38725672

Authors

V Michael Holers

Rachel M Frank

Michael Zuscik

Carson Keeter

Robert I Scheinman

Christopher Striebich

Dmitri Simberg

Michael R Clay

Larry W Moreland

Nirmal K Banda

Affiliations

Soon will be listed here.

Abstract

We have reported that anterior cruciate ligament (ACL) injury leads to the differential dysregulation of the complement system in the synovium as compared to meniscus tear (MT) and proposed this as a mechanism for a greater post-injury prevalence of post traumatic osteoarthritis (PTOA). To explore additional roles of complement proteins and regulators, we determined the presence of decay-accelerating factor (DAF), C5b, and membrane attack complexes (MACs, C5b-9) in discarded surgical synovial tissue (DSST) collected during arthroscopic ACL reconstructive surgery, MT-related meniscectomy, osteoarthritis (OA)-related knee replacement surgery and normal controls. Multiplexed immunohistochemistry was used to detect and quantify complement proteins. To explore the involvement of body mass index (BMI), after these 2 injuries, we examined correlations among DAF, C5b, MAC and BMI. Using these approaches, we found that synovial cells after ACL injury expressed a significantly lower level of DAF as compared to MT (p<0.049). In contrast, C5b staining synovial cells were significantly higher after ACL injury (p<0.0009) and in OA DSST (p<0.039) compared to MT. Interestingly, there were significantly positive correlations between DAF & C5b (r=0.75, p<0.018) and DAF & C5b (r=0.64 p<0.022) after ACL injury and MT, respectively. The data support that DAF, which should normally dampen C5b deposition due to its regulatory activities on C3/C5 convertases, does not appear to exhibit that function in inflamed synovia following either ACL injury or MT. Ineffective DAF regulation may be an additional mechanism by which relatively uncontrolled complement activation damages tissue in these injury states.

Citing Articles

iTRAQ proteomic analysis of exosomes derived from synovial fluid reveals disease patterns and potential biomarkers of Osteoarthritis.

Wu X, Li H, Meng F, Lui T, Pan X J Orthop Surg Res. 2024; 19(1):849.

PMID: 39702169 PMC: 11658229. DOI: 10.1186/s13018-024-05336-0.

References

Nicholson-Weller A, Burge J, Austen K . Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a. J Immunol. 1981; 127(5):2035-9. View

Egan E, Jiang R, Moechtar M, Barteneva N, Weekes M, Nobre L . Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion. Science. 2015; 348(6235):711-4. PMC: 4465434. DOI: 10.1126/science.aaa3526. View

Holers V, Frank R, Clauw A, Seifert J, Zuscik M, Asokan S . Potential causal role of synovial complement system activation in the development of post-traumatic osteoarthritis after anterior cruciate ligament injury or meniscus tear. Front Immunol. 2023; 14:1146563. PMC: 10189880. DOI: 10.3389/fimmu.2023.1146563. View

Li Q, Huang D, Nacion K, Bu H, Lin F . Augmenting DAF levels in vivo ameliorates experimental autoimmune encephalomyelitis. Mol Immunol. 2009; 46(15):2885-91. PMC: 2753188. DOI: 10.1016/j.molimm.2009.07.003. View

Fridkis-Hareli M, Storek M, Or E, Altman R, Katti S, Sun F . The human complement receptor type 2 (CR2)/CR1 fusion protein TT32, a novel targeted inhibitor of the classical and alternative pathway C3 convertases, prevents arthritis in active immunization and passive transfer mouse models. Mol Immunol. 2018; 105:150-164. PMC: 6331245. DOI: 10.1016/j.molimm.2018.09.013. View

Bharti R, Dey G, Lin F, Lathia J, Reizes O . CD55 in cancer: Complementing functions in a non-canonical manner. Cancer Lett. 2022; 551:215935. PMC: 11019835. DOI: 10.1016/j.canlet.2022.215935. View

van den Wijngaard R, Asghar S, Pijnenborg A, Tigges A, Westerhof W, Das P . Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo. Br J Dermatol. 2002; 146(1):80-7. DOI: 10.1046/j.1365-2133.2002.04604.x. View

Brown T, Johnston R, Saltzman C, Marsh J, Buckwalter J . Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma. 2006; 20(10):739-44. DOI: 10.1097/01.bot.0000246468.80635.ef. View

Banda N, Deane K, Bemis E, Strickland C, Seifert J, Jordan K . Analysis of Complement Gene Expression, Clinical Associations, and Biodistribution of Complement Proteins in the Synovium of Early Rheumatoid Arthritis Patients Reveals Unique Pathophysiologic Features. J Immunol. 2022; 208(11):2482-2496. PMC: 9133225. DOI: 10.4049/jimmunol.2101170. View

10.

Ozen A, Comrie W, Ardy R, Conde C, Dalgic B, Beser O . CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med. 2017; 377(1):52-61. PMC: 6690356. DOI: 10.1056/NEJMoa1615887. View

11.

Cuellar V, Cuellar J, Golish S, Yeomans D, Scuderi G . Cytokine profiling in acute anterior cruciate ligament injury. Arthroscopy. 2010; 26(10):1296-301. DOI: 10.1016/j.arthro.2010.02.011. View

12.

Wang Q, Rozelle A, Lepus C, Scanzello C, Song J, Larsen D . Identification of a central role for complement in osteoarthritis. Nat Med. 2011; 17(12):1674-9. PMC: 3257059. DOI: 10.1038/nm.2543. View

13.

Wang L, Zeng N, Yan Z, Li J, Ni G . Post-traumatic osteoarthritis following ACL injury. Arthritis Res Ther. 2020; 22(1):57. PMC: 7092615. DOI: 10.1186/s13075-020-02156-5. View

14.

Medof M, Kinoshita T, NUSSENZWEIG V . Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med. 1984; 160(5):1558-78. PMC: 2187498. DOI: 10.1084/jem.160.5.1558. View

15.

Pangburn M, Schreiber R, MULLER-EBERHARD H . Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci U S A. 1983; 80(17):5430-4. PMC: 384270. DOI: 10.1073/pnas.80.17.5430. View

16.

Qiao P, Dang E, Fang H, Zhang J, Li B, Shen S . Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid. Oncotarget. 2018; 9(85):35517-35527. PMC: 6238980. DOI: 10.18632/oncotarget.21216. View

17.

Nasu J, Mizuno M, Uesu T, Takeuchi K, Inaba T, Ohya S . Cytokine-stimulated release of decay-accelerating factor (DAF;CD55) from HT-29 human intestinal epithelial cells. Clin Exp Immunol. 1998; 113(3):379-85. PMC: 1905071. DOI: 10.1046/j.1365-2249.1998.00660.x. View

18.

Spiller O, Rodriguez de Cordoba S, Morgan B . Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack. Clin Exp Immunol. 2000; 121(2):234-41. PMC: 1905706. DOI: 10.1046/j.1365-2249.2000.01305.x. View

19.

Racine J, Aaron R . Post-traumatic osteoarthritis after ACL injury. R I Med J (2013). 2014; 97(11):25-8. View

20.

Karpus O, Kiener H, Niederreiter B, Yilmaz-Elis A, van der Kaa J, Ramaglia V . CD55 deposited on synovial collagen fibers protects from immune complex-mediated arthritis. Arthritis Res Ther. 2015; 17:6. PMC: 4325944. DOI: 10.1186/s13075-015-0518-4. View